CLAIRE GREENBLATT: Open Payments
NPI 1881147221 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 10 payments from 6 companies in 2025. Trend: 2023 $374 · 2024 $285 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $73 |
| Amgen Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Recor Medical Inc | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Repatha, LEQVIO, Wegovy, Paradise Ultrasound Renal Denervation System, Ozempic, Rybelsus, FARXIGA, NEXLETOL.
Industry payments across NY — which companies pay providers there.
